Medical News

RSS

U.S. market for diabetes drugs, devices and monitoring systems to reach over $55 billion by 2016

According to a new report series by iData Research, the leading global authority in medical device, dental and pharmaceutical market research, the U.S. market for diabetes drugs, devices and monitoring systems will reach over $55 billion by 2016, tripling in value.

6 Oct 2009

NovImmune wins the 2009 EUROPEAN BIOTECHNICA AWARD

The winner of the 2009 EUROPEAN BIOTECHNICA AWARD is NovImmune SA from Switzerland. This biopharmaceutical company duly receives the lion’s share of the €100,000 prize money, which is awarded each year by Deutsche Messe AG and its partners. The aim of the award is to celebrate the achievements of innovative European companies in the field of biotechnology and the life sciences.

6 Oct 2009

Alere to showcase its Apollo integrated health management system at the Health 2.0 conference

Alere(®) LLC, a national patient-centered health management services company, has been selected to demonstrate its innovative integrated health management system, referred to as Apollo, at Health 2.0, a highly respected industry venue created to showcase web-based and mobile technologies transforming the healthcare system.

6 Oct 2009

MEF 21 certification for D-Link Xstack DES-3200 switch series

D-Link, the end-to-end computer networking solutions provider for consumer and business, today announced that its xStack® DES-3200 Series was one of the first product lines to receive MEF 21 certification from Iometrix test laboratory, the MEF authorized certification test lab.

6 Oct 2009

Resveratrol may help improve diet-induced diabetes

Resveratrol, a molecule found in red grapes, has been shown to improve diabetes when delivered orally to rodents. Until now, however, little has been known about how these beneficial changes are mediated in the body.

6 Oct 2009

Phase 3 results of Transdel's lead topical pain drug Ketotransdel announced

Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.

6 Oct 2009

Scientists expand their fleet of genomic next-generation sequencing technology to study about cancer

Scientists from the Baylor College of Medicine Human Genome Sequencing Center (HGSC) are expanding their fleet of advanced genomic next-generation sequencing technology from Applied Biosystems, part of Life Technologies Corporation to accelerate their studies of the genetic underpinnings of cancer and other complex human diseases.

6 Oct 2009

Chattem announces financial results for the nine months and third fiscal quarter ended August 31, 2009

Chattem, Inc., a leading marketer and manufacturer of branded consumer products, today announced financial results for the nine months and third fiscal quarter ended August 31, 2009.

6 Oct 2009

Fat and muscle mass may contribute to diabetes risk

Fat and muscle mass, as potentially determined by a person's ethnic background, may contribute to diabetes risk, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

6 Oct 2009

New four-year accreditation for SCAN Health Plan's medical education program

SCAN Health Plan announced today that its continuing medical education program for physicians has received a new four-year accreditation from the Institute of Medical Quality.

6 Oct 2009

Vantia Therapeutics announces the start of Phase II proof-of-concept trials of its VA111913 drug

Vantia Therapeutics today announces that its novel oral small molecule drug for the treatment of dysmenorrhoea (painful menstruation) has entered Phase II proof-of-concept trials. In addition, Vantia announces results of the successful Phase I trial of VA111913, which showed the product candidate to be safe and well tolerated.

6 Oct 2009

LMA Stonebreaker and Holmium Lasers to feature at 27th World Congress on Endourology

Continuing to drive innovation in endourology, Cook Medical will feature a series of product demonstrations and interactive presentations with a special emphasis on kidney stone management solutions, including the LMA Stonebreaker and Holmium Lasers at the 27th Annual World Congress on Endourology and SWL (shock wave lithotripsy) at the Sheraton Grand Hotel in Munich, Germany from 6-10 October.

6 Oct 2009

PDS Biotechnology's Versamune-based immunotherapy drug demonstrates safety in preclinical studies

PDS Biotechnology Corporation today announced that the company has completed GLP toxicology studies of its lead HPV-cancer product. The studies, which included pharmacokinetic (PK) and adsorption, bio-distribution and excretion (ADE) studies in addition to the evaluation of toxicity, all demonstrated a very safe profile of the drug and PDS Biotech's platform Versamune((TM)) technology.

6 Oct 2009

It is possible to communicate through power of thought alone: Study

New research from the University of Southampton has demonstrated that it is possible for communication from person to person through the power of thought alone.

6 Oct 2009

Ground Zero Pharmaceuticals opens new office in Brisbane

A major increase in innovative concepts for exciting therapeutic and preventive new products in Australia has led to an expansion of GZP's activities Down Under, to better support clients in their efforts to take their programs to the US Food and Drug Administration.

6 Oct 2009

The latest medication to treat schizophrenia "ABILIFY" launched in Canada

A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.

6 Oct 2009

Mirth Corporation announces the launch of Mirth Meaningful Use Exchange

Mirth Corporation, the leader in commercial open source healthcare information technology, today announced the launch of Mirth Meaningful Use Exchange (Mirth MUx) as well as the first Mirth MUx implementation at Thayer County Health Services (TCHS).

6 Oct 2009

Hepatitis B Foundation calls for consistent monitoring and referral of HBV infected children

An expert panel of nationally recognized pediatric liver specialists convened by the Hepatitis B Foundation is calling for more consistent monitoring and referral of children chronically infected with the hepatitis B virus (HBV). The panel's recommendations for pediatricians and other primary care practitioners stress the need for routine monitoring of children with chronic HBV infections, and timely consultation with a pediatric liver specialist.

6 Oct 2009

BIOBASE to integrate its TRANSFAC database with CLC bio's popular workbenches

Today at the Biotechnica / Bio-IT World Europe conference in Hannover, Germany, BIOBASE and CLC bio announced a partnership to integrate BIOBASE's comprehensive TRANSFAC® database with CLC bio's popular workbenches and award-winning server solution.

6 Oct 2009

New line of waterproof headphones from H2O Audio

H2O Audio (www.h2oaudio.com), the leader in high performance sweatproof and waterproof headphones and accessories for active people everywhere, today unveiled three progressive new products.

6 Oct 2009

Medical News

U.S. market for diabetes drugs, devices and monitoring systems to reach over $55 billion by 2016

NovImmune wins the 2009 EUROPEAN BIOTECHNICA AWARD

Alere to showcase its Apollo integrated health management system at the Health 2.0 conference

MEF 21 certification for D-Link Xstack DES-3200 switch series

Resveratrol may help improve diet-induced diabetes

Phase 3 results of Transdel's lead topical pain drug Ketotransdel announced

Scientists expand their fleet of genomic next-generation sequencing technology to study about cancer

Chattem announces financial results for the nine months and third fiscal quarter ended August 31, 2009

Fat and muscle mass may contribute to diabetes risk

New four-year accreditation for SCAN Health Plan's medical education program

Vantia Therapeutics announces the start of Phase II proof-of-concept trials of its VA111913 drug

LMA Stonebreaker and Holmium Lasers to feature at 27th World Congress on Endourology

PDS Biotechnology's Versamune-based immunotherapy drug demonstrates safety in preclinical studies

It is possible to communicate through power of thought alone: Study

Ground Zero Pharmaceuticals opens new office in Brisbane

The latest medication to treat schizophrenia "ABILIFY" launched in Canada

Mirth Corporation announces the launch of Mirth Meaningful Use Exchange

Hepatitis B Foundation calls for consistent monitoring and referral of HBV infected children

BIOBASE to integrate its TRANSFAC database with CLC bio's popular workbenches

New line of waterproof headphones from H2O Audio

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News